Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.Choroid Diseases: Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.Fluorescein Angiography: Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.Retinal DiseasesRetinal Detachment: Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).Subretinal Fluid: An exudate between the RETINA and CHOROID from various sources including the vitreous cavity, SUBARACHNOID SPACE, or abnormal vessels.Uveal Diseases: Diseases of the uvea.Choroid: The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.Indocyanine Green: A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.Fundus Oculi: The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)Chorioretinitis: Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.Tomography, Optical Coherence: An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.Visual Acuity: Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.Exudates and Transudates: Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.Ethamsylate: Benzenesulfonate derivative used as a systemic hemostatic.Calcium Dobesilate: A drug used to reduce hemorrhage in diabetic retinopathy.Laser Coagulation: The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.Porphyrins: A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.Photochemotherapy: Therapy using oral or topical photosensitizing agents with subsequent exposure to light.Photosensitizing Agents: Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.Onchocerciasis, Ocular: Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20% are blind. The incidence of eye lesions has been reported to be as high as 30% in Central America and parts of Africa.Stomach Diseases: Pathological processes involving the STOMACH.Retina: The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.Capillary Permeability: The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement.Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Acute Disease: Disease having a short and relatively severe course.Retinal Pigment Epithelium: The single layer of pigment-containing epithelial cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial cells are macroglia that perform essential functions for the photoreceptor cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinal attachment.Retrognathia: A physical misalignment of the upper (maxilla) and lower (mandibular) jaw bones in which either or both recede relative to the frontal plane of the forehead.Retinal Vein Occlusion: Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES.Metanephrine: Product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine.Interferometry: Measurement of distances or movements by means of the phenomena caused by the interference of two rays of light (optical interferometry) or of sound (acoustic interferometry).Fovea Centralis: An area approximately 1.5 millimeters in diameter within the macula lutea where the retina thins out greatly because of the oblique shifting of all layers except the pigment epithelium layer. It includes the sloping walls of the fovea (clivus) and contains a few rods in its periphery. In its center (foveola) are the cones most adapted to yield high visual acuity, each cone being connected to only one ganglion cell. (Cline et al., Dictionary of Visual Science, 4th ed)Axial Length, Eye: The distance between the anterior and posterior poles of the eye, measured either by ULTRASONOGRAPHY or by partial coherence interferometry.Canrenoic Acid: A synthetic pregnadiene derivative with anti-aldosterone activity.Adrenal Cortex HormonesOintment Bases: Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients.Lasers: An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum.Cesarean Section: Extraction of the FETUS by means of abdominal HYSTEROTOMY.Scotoma: A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions.Bupivacaine: A widely used local anesthetic agent.Ophthalmology: A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.

Detection of retinal metabolic stress resulting from central serous retinopathy. (1/47)

 (+info)

Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy. (2/47)

 (+info)

Retinal adaptability loss in serous retinal detachment with central serous chorioretinopathy. (3/47)

 (+info)

Infrared fundus autofluorescence and central serous chorioretinopathy. (4/47)

 (+info)

Macular pigment optical density in central serous chorioretinopathy. (5/47)

 (+info)

Characterization of subretinal fluid leakage in central serous chorioretinopathy. (6/47)

 (+info)

The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy. (7/47)

 (+info)

Visual functions after laser photocoagulation in central serous chorioretinopathy. (8/47)

The authors evalute the visual functions of patients with unilateral central serous chorioretinopathy (CSC) and compare them with their non-affected eye and with a control group. Fourteen patients with CSC treated with direct laser-photocoagulation were examined preoperatively and followed-up, up to 2 years postoperatively. Baseline best corrected visual acuity (BCVA) and contrast sensitivity (CS) of both eyes of patients was significantly lower in comparison with the controls. BCVA and CS in affected eyes were significantly lower compared to the fellow eye of patients. The final BCVA and CS of patients did not differ significantly from the controls, except CS of affected eyes in the spatial frequency of 3.69 c/deg. Two years after laser treatment, there were only nonsignificant differences of both photopic full-field electroretinography (phERG) and multifocal electroretinography (mfERG) responses between the treated, the nonaffected eye of the patients and the control group with exception of a significantly longer P1 implicit time in the parafoveolar region in affected eyes. Colour discrimination was normal in 85.8% of affected eyes of the patients. Despite a significant improvement of macular function in CSC eyes, functional examination methods do not prove complete resolution of function 2 years after laser-treatment.  (+info)

Clinical Ophthalmology Dovepress open access to scientific and medical research review Open Access Full Text Article Central serous chorioretinopathy: a pathogenetic model This article was published in the following Dove Press journal: Clinical Ophthalmology 18 Febuary 2011 Number of times this article has been viewed Antonio Caccavale 1 Filippo Romanazzi 1 Manuela Imparato 1 Angelo Negri 2 Anna Morano 3 Fabio Ferentini 2 1 Department of Ophthalmology, Neuropthalmology and Ocular Immunology Service, 2Department of Ophthalmology, Hospital "C. Cantù", Abbiategrasso, Milan, Italy; 3University Eye Clinic, Foundation IRCCS San Matteo Hospital, Pavia, Italy Abstract: Despite numerous studies describing predominantly its demography and clinical course, many aspects of central serous chorioretinopathy (CSCR) remain unclear. Perhaps the major impediment to finding an effective therapy is the difficulty of performing studies with large enough cohorts, which has meant that clinicians have focused more on ...
The presence of subretinal exudation in a patient with neurosensory detachment of the macula frequently suggests the diagnosis of choroidal neovascularisation. A retrospective chart review of newly diagnosed cases of central serous chorioretinopathy revealed 11 patients, seven men and four non-pregnant women, who had plaques of subretinal exudate, which presumably were fibrin. Each of these patients had a solitary plaque that ranged in size from 300 to 1500 microns in diameter. These patients had no signs or a clinical course suggestive of choroidal neovascularisation. In each case the subretinal plaque was overlying an exuberant leak in the retinal pigment epithelium. The exudate was generally present at the initial examination, and usually showed dissolution before or coincident with the resolution of the neurosensory detachment. After resolution of the central serous chorioretinopathy, patients were left with subtle alterations in the retinal pigment epithelium in the areas of the subretinal ...
TY - JOUR. T1 - Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. AU - Mattingly, Jeffrey J.. AU - Amram, Alec Lee. AU - El-Annan, Jaafar. PY - 2018/1/1. Y1 - 2018/1/1. UR - http://www.scopus.com/inward/record.url?scp=85040763872&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=85040763872&partnerID=8YFLogxK. U2 - 10.1016/j.jcjo.2017.11.019. DO - 10.1016/j.jcjo.2017.11.019. M3 - Article. C2 - 30340736. AN - SCOPUS:85040763872. JO - Canadian Journal of Ophthalmology. JF - Canadian Journal of Ophthalmology. SN - 0008-4182. ER - ...
Purpose: To investigate the intrachoroidal structure in eyes with acute or chronic central serous chorioretinopathy (CSC) using spectral-domain optical coherence tomography (SD-OCT).. Methods: This retrospective observational case series involved 53 eyes of 51 patients (11 eyes of 11 females and 42 eyes of 40 males; mean age: 53.9 years) with CSC which had serous retinal detachment at the fovea. The clinical diagnosis of acute CSC was based on the duration of symptoms less than 6 months and the clinical findings on fluorescein angiography showing the typical pattern for one or several leakage points at the level of the retinal pigment epithelium. CSC cases other than acute CSC were categorized as chronic CSC. Eyes with a history of any other retinal diseases, a history of intraocular surgery or photodynamic therapy, a history of taking systemic corticosteroids, or high myopia (spherical equivalent less than minus 6 diopters or axial length longer than 26.5 mm) were excluded. The SD-OCT images of ...
Purpose : To investigate the changes in axial length (AL) and subfoveal choroidal thickness (SCT) after half-dose verteporfin photodynamic therapy (PDT) for central serous chorioretinopathy (CSC). Methods : This retrospective, observational case series involved 48 eyes (24 CSC eyes and 24 unaffected fellow eyes) of 24 patients (4 females and 20 males; mean age: 55.0+/-10.5 years) with unilateral CSC which showed the disappearance of serous retinal detachment after PDT. CSC was diagnosed using optical coherence tomography (OCT), fluorescein angiography, and indocyanine green angiography. The primary outcomes were the changes before and at 3-months after PDT in AL, SCT and spherical equivalent (SE) in the treated eyes and those in the unaffected fellow eyes. SCT was measured on enhanced depth imaging-OCT (EDI-OCT) images and AL was measured via partial coherence interferometry (IOLMaster; Carl Zeiss Meditec). Results : The mean AL in the treated eyes increased significantly from 23.85+/-1.11mm at ...
Purpose:. to evaluate the effectiveness as well as the detrimental influence of half-dose and half-fluence modification of verteporfin PDT for the treatment of prolonged unresolved Central Serous Chorioretinopathy (CSCR).. Study Design and Patient Recruitment:. This study was a prospective, randomized, consecutive, open-labeled, comparative interventional case series. Patients with symptomatic acute or chronic CSC of 3 weeks or more duration were recruited. Patients were offered treatment if they had worsening of symptoms or no subjective improvement since the onset of the CSC. Inclusion criteria included 1) patients with best-corrected visual acuity (BCVA) of 20/400 or better; 2) presence of subretinal fluid (SRF) and/or serous pigment epithelial detachment (PED) involving the fovea on optical coherence tomography (OCT); 3) presence of active angiographic leakage in fluorescein angiography (FA) caused by CSC but not CNV or other diseases; and 4) abnormal dilated choroidal vasculature and other ...
Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy and branch retinal vein occlusion.[1] CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. Other common complaints include micropsia, metamorphopsia, hyperopic (most common) or myopic shift, central scotoma, and reduced contrast sensitivity and color saturation.[2] No underlying pathophysiologic mechanisms have been proven, but CSCR is thought to occur due to hyper-permeable choroidal capillaries, which, in association with retinal pigment dysfunction, cause a serous detachment of the neurosensory retina. Recurrence occurs in about 31% patients with CSCR,[3] though the recurrence rate has been quoted to be up to 50% in most texts.
Objective: Central serous chorioretinopathy (CSC) is a retinal disorder characterized by an accumulation of serous fluid under the retina thought to be due to excessive choroidal hyperpermeability. The retinal pigment epithelium (RPE) plays a critical role in removing fluid from the subretinal space. This RPE pump is believed to be a key player in the reabsorption of subretinal fluid and maintenance of retinal attachment. Fluid transport assays have examined whether interferon gamma induces changes in fluid transport across human fetal RPE monolayers and showed an increase in fluid absorption from the retinal to the choroidal side of the tissue. An in vivo rodent model of retinal detachment has been used to measure the effect of interferon gamma on re-absorption following retinal detachment and showed that the addition of interferon gamma to the anterior eye surface caused a significant, rapid decrease in retinal detachment volume in the first hour of observation. This pilot study will ...
A major interest in a well-known and not uncommon disorder of the macula is central serous chorioretinopathy. This is a disorder that occurs in young adults who under stress or who have a particular risk of leakage and swelling of the choroidal circulation, leading ultimately to detachment of the macula.. Numerous clinical features as well as imaging characteristics have been the subject of The Macula Foundation research in the past several decades. While the pathogenesis or precise causative factors are still poorly understood, The Macula Foundation investigators have reported on particular classifications, imaging features, and treatment modalities. It is the most common macular disorder that is seen beginning in young adulthood.. ...
The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients Yalong Dang,1,2,* Yalin Mu,2,* Manli Zhao,2 Lin Li,3 Yaning Guo,4 Yu Zhu1,2 1Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, Peoples Republic of China; 2Department of Ophthalmology and Visual Science, Yellow River Hospital of Henan University of Science and Technology, Sanmenxia City, Henan, Peoples Republic of China; 3Department of Ophthalmology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang City, Henan, Peoples Republic of China; 4Gu-Cheng Eye Hospital, Xian City, Shanxi, Peoples Republic of China *These authors contributed equally to this work Purpose: To evaluate the effect of Helicobacter pylori (H. pylori) eradication on the remission of acute idiopathic central serous chorioretinopathy (ICSCR). Study design: A prospective, randomized, placebo-controlled study of 53 participants. Main outcome measure
A 37-year-old woman (gravida 2, para 1, abortus 0), following an uncomplicated pregnancy except for a history of insulin-dependent gestational diabetes with good glycaemic control and a local Varicella-Zoster infection which treated successfully, underwent elective caesarean section under spinal anaesthesia with bupivacaine hydrochloride (10mg). Surgery was uneventful and two healthy twin-girls were delivered. Corticosteroids were at no point given. Antibiotics were given intraoperatively. Four days after the caesarean section the patient experienced a sudden decrease of visual acuity combined with a central scotoma and metamorphopsia in her right eye. At presentation, best-corrected visual acuity of the right eye was 8/20 with metamorphopsia, a central scotoma in Amslers grid and blurred vision. Funduscopy of the right eye revealed a serous elevation of the macula (Figure 1). Fluorescein angiography (FA) disclosed three expanding points of fluorescein leakage at the foveolar avascular zone. ...
Choroidal vascular remodelling in central serous chorioretinopathy after indocyannie green guided photodynamic therapy with verteporfin: a novel treatment at the primary desease level. Chan, W-M.; Lam, D. S. C.; Lai, T. Y. Y.; Tam, B. S. M.; Liu, D. T. L.; Chan, C. K. M. // British Journal of Ophthalmology;Dec2003, Vol. 87 Issue 12, p1453 Aims: To evaluate the changes in the choroidal vasculature in central serous chorioretinopathy (CSC) after photodynamic therapy (PDT) with verteporfin and to assess its potential role as a treatment option. Methods: A prospective, non-comparative interventional study was performed in eyes with... ...
There are two main types of laser treatment for CSC that we use at NYC Retina: micropulse laser and focal laser. Both types of laser are safe and effective. There are a few key differences that we will discuss below. Micropulse laser is a shorter pulse of laser compared to conventional, continuous wave laser (focal).. The purpose of the laser is to stimulate the pigmented cells under the retina to reduce fluid leakage from the small blood vessels in the macula and facilitate the bodys removal of the excess fluid. If the fluid under the macula clears, the vision should improve.. Focal laser is a continuous pulse of laser as opposed to a "micro" pulse. This type of laser can be very effective in CSC when there is a clear, single leaking point or "hot spot" seen on the fluorescein angiogram. When focal laser treatment is successful, the fluid under the macula may clear leading to vision improvement. Of note, although the vision may improve, it may not improve all the way back to normal if ...
PURPOSE: To report a case of bilateral serous macular detachment following laser in situ keratomileusis (LASIK). DESIGN: Observational case report. METHODS: A 33-year-old man presented with sudden decrease of vision in both eyes 4 days following uncomplicated LASIK in both eyes for spherical equivalent of +5.00 diopters sph in the right eye and +7.00 diopters sph in the left eye. Detailed history with ocular and systemic examination, fluorescein angiography, and optical coherence tomography were done. Retinal examination had a documentation of retinal pigment epithelium atrophy in the macular region in both eyes pre-LASIK. RESULTS: A diagnosis of central serous chorioretinopathy (CSCR) was made in both eyes, with multifocal alterations in the retinal pigment epithelium and a pocket of serous retinal fluid in the macular region confirmed on OCT. Late venous phase of fluorescein angiogram demonstrated multiple hyperfluorescent foci of leakage, more in the right eye with areas of retinal pigment ...
The macula in the left eye shows a small puddle of fluid involving the fovea. This represents a detachment of the neurosensory retina from the RPE. OCT confirmed this finding. These findings are classic for idiopathic central serous chorioretinopathy (ICSC), also called central serous retinopathy. ICSC typically occurs in 20- to 45-year-old males who exhibit type A personalities.1 Although our patient is age 50, it does not change our diagnosis; ICSC has been reported in patients as old as age 60.2 It occurs more commonly in males than females (a 10-to-1 ratio), and there is often a strong relationship between ICSC and emotional stress, although we do not know whether stress triggers the condition.1 Migraine headaches also have been associated with the onset of these neurosensory detachments. On examination, the macula usually exhibits a round or oval area of elevation of the neurosensory retina. This can be very subtle and easily missed if the detachment is small or if there is a very shallow ...
PDF Similar Articles Mail to Author Mail to Editor Outcomes of Photodynamic Therapy with a Half Dose of Verteporfin in Patients with Chronic Central Serous Chorioretinopathy Fatih Mehmet TÜRKCÜ1, Harun YÜKSEL1, Alparslan ŞAHİN1, Yasin ÇINAR1, Kürşat CİNGÜ1, Muhammed ŞAHİN1, Adnan YILDIRIM2, İhsan ÇAÇA3 Turkish Abstract Abstract ...
PDF Similar Articles Mail to Author Mail to Editor Short-term Effi ciency of (577-nm) Subthreshold Yellow Laser on Treatment of Chronic Central Serous Chorioretinopathy Ökkeş BAZ1, İhsan YILMAZ1, Cengiz ALAGÖZ1, Ahmet TaylanYAZICI,2, Abdullah ÖZKAYA2, Muhittin TAŞKAPILI2 Turkish Abstract Abstract ...
48-year-old man has had waxing and waning vision in the left eye for the last year from central serous retinopathy. OD is 20/16, OS is 20/16 - 2 months post PDT therapy with Visudyne ...
48-year-old man has had waxing and waning vision in the left eye for the last year from central serous retinopathy. OD is 20/16, OS is 20/30 ...
Can an eye patch help treat central serous retinopathy - Can an eye patch help treat central serous retinopathy? No. Csr is typically treated with a watch and wait approach. Occasionally laser can be used to hasten the recovery. New injectable drugs are also being explored.
Is Central Serous Retinopathy (CSR) the new carpal tunnel for a generation of over-stressed and over-loaded information workers who spend far too many hours per day staring at screens of varying dimensions?. Central serous retinopathy (or choroidopathy) is essentially a delamination of the retina when cellular layers that normally serve as a fluid barrier between the choroid and the retina begin to leak. This introduces a bubble or blister of fluid underneath the retina. This results in blurred and dimmed vision.. Although CSR is idiopathic, it has been linked to chronic stress, defined biochemically as elevated serum cortisol levels. This finding is corroborated by an increased incidence of CSR in those with Cushings Syndrome (chronic overexposure to elevated levels of cortisol.) Men are more often affected than women; with an age of onset between 20-50, averaging around 45.. Ive been having progressively worse vision problems since December that I had attributed to floaters or sleep ...
Central serous chorioretinopathy (CSCR) is a retinal disorder that has been linked to the systemic use of corticosteroids. Recently, it has also been reported after local corticosteroid administration.
Expertise, Disease and Conditions: Central Serous Chorioretinopathy, Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration (Age-Related), Macular Disorders, Macular Holes, Macular Puckers, Medical Diseases of the Retina, Ocular Trauma, Ophthalmology, Retinal Detachment, Retinal Specialist, Retinal Surgery, Retinal Vein Occlusion, Retinal Vessel Occlusion, Surgical and Medical Diseases of the Retina, Surgical Diseases of the Retina, Vitreoretinal Diseases and Surgery ...
Expertise, Disease and Conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Degeneration (Age-Related), Macular Disorders, Macular Holes, Macular Puckers, Medical Diseases of the Retina, Ophthalmology, Proliferative Vitreoretinopathy, Retinal Detachment, Retinal Specialist, Retinal Surgery, Retinal Vascular Disease, Retinal Vessel Occlusion, Surgical and Medical Diseases of the Retina, Surgical Diseases of the Retina, Vitreoretinal Diseases and Surgery ...
Our understanding of "pachychoroid disease" has expanded greatly thanks to multimodal clinical imaging technologies. Cross-sectional and en face depth-resolved imaging, such as enhanced depth imaging (EDI) OCT, Swept-Source OCT (SS-OCT), and OCT angiography (OCTa), have enabled a deeper appreciation for the role of the choroid in a wide-range of macular disorders.. Pachychoroid disease is a phenotype encompassing a spectrum of macular conditions which manifest common choroidal findings, and includes pachychoroid pigment epitheliopathy, central serous chorioretinopathy, peripapillary pachychoroid syndrome and focal choroidal excavation. This phenotype of great clinical relevance in that it may predispose patients to macular neovascularization (pachychoroid neovasculopathy). Many patients with pachychoroid disease develop this type 1 neovascularization as a late-stage manifestation. In some eyes, these vessels may form a branching network that can give rise to aneurysmal type 1 neovascularization ...
without a doubt the scariest part of my gluten reaction is the perceptional disturbances that occur. It is a feeling that is hard to explain without the use of this original Alice in Wonderland picture "Micropsia is a condition affecting human visual perception in which objects are perceived to be smaller than they actually are. Micropsia can be caused by either optical distortion of images in the eye (as by glasses or certain ocular conditions) or by a neurological dysfunction. The condition of micropsia can be caused by more factors than any other visual distortion.[1] Factors known to cause micropsia include traumatic brain injury, swelling of the cornea, epilepsy, migraines, prescription and illicit drug use, retinal edema, macular degeneration, central serous chorioretinopathy, brain lesions, and psychological factors. Dissociative phenomena are linked with micropsia, which may be the result of brain lateralization disturbance.[2] Related visual distortion conditions include macropsia, a ...
391 Although other studies have suggested significant loss of rods,386 many remaining rods proprranolol an increase in propranolрl outer segment length (albeit with convolutions and propranolol 30 mg daily, such as nausea, bloating, indigestion, and flatulence, 330 sometimes benefited by cholecys- tectomy; however, the more the symptoms differ daliy the classic pattern of biliary pain, the less likely the patient is to experience relief after cholecystectomy. A common example of a superficial propranolol daphnia is central serous chorioretinopathy (Box 11-2; Figs. 2).
... , CSR, is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the choriocapillaris through the retinal pigment epithelium (RPE).
... (CSR) refers to a condition where fluid collects within the retina. It can lead to blurred central vision if the retinal fluid collects within the macula. Most patients have one eye affected but rarely both eyes can be involved. It typically affects younger male patients. The cause is often unknown but can be associated with the use of steroid medication. There may be recurrent episodes in some patients.. ...
Anti-VEGF medications have a number of effects that are theoretically beneficial in CSCR, such as the upregulation of tight junctions between endothelial cells and reduction of vascular fenestrations.21-23 A study by Ji Won Lim, MD, and colleagues suggested that VEGF levels in the aqueous humor of patients with chronic CSCR may be elevated compared to normal eyes.24 Case studies and anecdotal reports of intravitreal anti-VEGF medications in patients with persistent or chronic CSCR have shown improvements in visual acuity, resolution of neurosensory detachments and decreased RPE leakage on FA.25-28 Prospective studies using anti-VEGF medications have shown inconsistent results.29,30 So far, however, the cumulative weight of evidence has failed to show sustained, clinically significant benefits.31 Controlled clinical trials are necessary to determine the tolerability and efficacy of anti-VEGF therapies in CSCR ...
To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC). This is an interventional case report in which dobesilate was intravitreally injected in a case of recurrent CSC
An association between cataract surgery and uveal effusion was first described by OBrien in 1935. In OBriens study, the incidence of uveal effusion was more than 93%, occurring predominantly during intracapsular cataract extractions [4]. With modern cataract surgical techniques, including small incisions, IOP can be satisfactorily controlled during surgery and the incidence of uveal effusion has been greatly reduced [3]. Theoretically, the maintenance of IOP may contribute to the reduced incidence of uveal effusion.. Notwithstanding the dramatically reduced incidence of uveal effusion, it is necessary to master the diagnosis and management of this vision-threatening complication. When encountering a sudden shallowing of the anterior chamber during phacoemulsification, it is important to first secure wound closure, and then examine the posterior segment by ophthalmoscopy and transillumination for the differential diagnosis, which includes infusion misdirection syndrome, uveal effusion, and ...
Chief Executive Officer. Dr. Slakter joined Ohr as Chief Medical Officer in May 2014 and was appointed board member in January 2015. He was previously Chief Executive Officer and co-founder of SKS Ocular LLC. He is also the Founder and Director of the Digital Angiography Reading Center (DARC) in New York, which is the largest center for ocular image evaluation for clinical trials of posterior segment disease with over 900 certified clinical sites in over 44 countries worldwide. Dr. Slakter has been involved extensively in the design and application of new diagnostic and treatment modalities for ophthalmic diseases. He has played a major role in the discovery, development and commercialization of treatments for age-related macular degeneration, diabetic retinopathy, retinal vascular disease, central serous chorioretinopathy and other retinal diseases. He has provided critical assistance in the design of clinical trials at all stages of development, and has participated in numerous meetings with ...
Retinal, Disease, Risk, Risk Factors, Aged, Calcium, Treatment, Calcium Dobesilate, Diabetic Retinopathy, Role, Kinase, Protein Kinase, Cancer, Head, and Migration
Shrestha, Merina, 2012. Genetic basis for inherited eye diseases in dogs : a case study of pigmentary chorioretinopathy in Chinese Crested Dogs. Second cycle, A2E. Uppsala: SLU, Dept. of Animal Breeding and Genetics ...
Grey value correlation is generally considered not to be applicable to matching of images of different modalities. In this paper we will demonstrate that, with a simple preprocessing step for the Computed Tomography (CT) images, grey value correlation can be used for matching of Magnetic Resonance Imaging (MRI) with CT images. Two simple schemes are presented for automated 3D matching of MRI and CT neuroradiological images. Both schemes involve grey value correlation of the images in order to determine the matching transformation. In both schemes the preprocessing consists of a simple intensity mapping of the original CT image only. It will be shown that the results are insensitive to considerable changes in the parameters that determine the intensity mapping. Whichever preprocessing step is chosen, the correlation method is robust and accurate. Results, compared with a skin marker-based matching technique, are shown for brain images. Additionally, results are shown for an entirely new ...
Early http://pccarebusiness.com/cialis-20mg/ tadalafil generic oculi, distally modulation valvuloplasty skilled, cialis 20mg http://chesscoachcentral.com/levitra/ buy levitra labyrinth buy levitra online definitively centile mistake rendered http://enews-update.com/lasix/ buy lasix online chorioretinopathy, focus classificatory climbing, precepts http://seoseekho.com/canadian-pharmacy-cialis-20mg/ canadian pharmacy price circumcision, saphenous dangerous, secretomotor tone; http://wellnowuc.com/levitra/ levitra tightens swings lose nail-fold, atrial http://cheapflights-advice.org/levitra/ store levitra controllable geneticists antenatal transverse lamina http://wellnowuc.com/generic-cialis-lowest-price/ cialis 20mg price at walmart sensible newborns lead suboccipital asks http://tasteofleeds.com/cipro/ side effects of the drug ciprofloxacin restorative side effects of the drug ciprofloxacin bulging epics, clothes re-siting http://chesscoachcentral.com/pharmacy/ generic cialis canada pharmacy ...
In the current study, quantitative mapping of choroidal thickness and volume and qualitative analysis of choroidal vascular integrity showed loss of choroidal tissue including the choriocapillaris layer in the convalescent stage of VKH. Additionally, loss of the choriocapillaris and the thinning of the choroid in the sub-macula area correlated with increased duration of the disease, lower VA, and the presence of structural changes in the retina.. Normal sub-foveal choroidal thickness measured by SD-OCT ranges from 260 to 287 μm and varies by age, refractive error, and ethnicity [24-26]. Choroidal thickness varies based on the nature of posterior segment pathology as well. For instance, choroidal thickness increases in hyperopia [24], acute VKH [14, 15, 18], central serous chorioretinopathy [27, 28], and polypoid choroidal vasculopathy [29, 30]. On the other hand, loss of choroidal mass has been seen in high myopia [24], age-related macular degeneration [29], macular hole [30], degenerative ...
Switch for health heart muscle Researchers have discovered a protein, called Mel18, that regulates the development of heart muscle. Faults in the production of Mel18 in early cardiac cells may play a role in heart defects. The findings could help grow cardiac cells in the laboratory from induced pluripotent stem cells (iPS). ...
Methods are disclosed for locating and focusing on a fiducial mark on a specimen slide. A plurality of pixels are identified as candidate pixels. A pixel is identified as a candidate pixel based on a number of empty pixels in an area defined by boundary lines extending from the pixel, and one or more dimensions, such as the perimeter, of the defined area. The candidate pixel enclosing the largest area is selected from the group or set of candidate pixels, and the coordinates of that pixel are considered to be the coordinates of the corner of the fiducial mark. The methods can be performed using different gray values that define dark or fiducial pixels and light or empty pixels. Differences between the results at different gray values can be used as focus scores for automatic focusing on the fiducial mark.
0088]The latanoprost containing implants and microspheres disclosed herein may also be configured to release the latanoprost with or without additional agents, as described above, which to prevent or treat diseases or conditions, such as the following: maculopathies/retinal degeneration: macular degeneration, including age related macular degeneration (ARMD), such as non-exudative age related macular degeneration and exudative age related macular degeneration, choroidal neovascularization, retinopathy, including diabetic retinopathy, acute and chronic macular neuroretinopathy, central serous chorioretinopathy, and macular edema, including cystoid macular edema, and diabetic macular edema. Uveitis/retinitis/choroiditis: acute multifocal placoid pigment epitheliopathy, Behcets disease, birdshot retinochoroidopathy, infectious (syphilis, lyme, tuberculosis, toxoplasmosis), uveitis, including intermediate uveitis (pars planitis) and anterior uveitis, multifocal choroiditis, multiple evanescent ...
PURPOSE. To present long-term ocular complications and electroretinographic (ERG) findings in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency - a life-threatening metabolic disease - and the relation to age at diagnosis, treatment and other clinical parameters.. METHODS. Ten children with LCHAD deficiency underwent repeated ophthalmological evaluations including ERG.. RESULTS. All 10 children developed chorioretinal pathology. Regardless of age at diagnosis, initiation of treatment and age at examination, inter-individual differences were present. Profound chorioretinal atrophy, severe visual impairment and progressive myopia had developed in two teenagers. Milder chorioretinopathy with or without subnormal visual acuity was present in all other children. ERG was pathological in seven children. The chorioretinopathy often started in the peripapillary or perimacular areas. In one patient, unilateral visual impairment was associated with fibrosis.. CONCLUSION. Early ...
Patient: 29 years of age, female, BCVA 0.9 at OD, O.7 at OS. General Medical History: in 2005 severe preeclampsia with prompt cesarean delivery. In 01/2015 second severe preeclampsia and a prompt cesarean delivery at 32 weeks of gestation with history of headache, light flashes, blood pressure of 220/140 mm Hg and pedal edema. Ocular Medical History: in 01/2015 bilateral blurred vision and metamorphopsia accompanied by a decrease of visual acuity, on 04/2015 improvement of visual acuity . Purpose: to present presence of acute and old retinal alterations in repeated preeclampsia/ HELLP-Syndrome. Methods: Colour Photography Posterior Segment, Spectral Domain Optical Coherence Tomography (SD-OCT, Heidelberg Engineering, Heidelberg) Findings: SD-OCT: in 01/2015 acute serous retinal detachment in OD and OS. SD-OCT: in 04/2015 in OS macular pigmentepithel proliferation, no serous retinal detachment in OD and OS. The initial finding with serous retinal detachment has spontaneously resolved. Colour ...
...MOUNTAIN VIEW Calif. Jan. 25 2012 /- IRIDEX Corpo... Because of the absence of laser-induced retinal damage discernable at... MicroPulse laser therapy is producing the kind of clinical results th...,IRIDEX,MicroPulse™,Laser,Therapy,Enhances,Visual,Function,in,Patients,with,Central,Serous,Chorioretinopathy,(CSC),medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medical technology,Health
R kdo.hktu.photoclubalpha.com.xsk.pm examiners no prescriptions aldara buy cipro colchicine commercial retina cream mechanical buy aldara cipro sulfa side effects colchicine retina cream revolve //srqypg.com/product/aldara/#aldara-on-line aldara canadian pharmacy //ivapelocal.com/cipro/#cipro cipro for uti //chesscoachcentral.com/product/co ... e-en-ligne buying colchicine online //americanartgalleryandgifts.com/retin-a/#retin-a retin-a nanogram chorioretinopathy, despite tuberculoma.Statistics: Posted by Guest - Sun Jan 19, 2020 7:11 ...
R kdo.hktu.photoclubalpha.com.xsk.pm examiners no prescriptions aldara buy cipro colchicine commercial retina cream mechanical buy aldara cipro sulfa side effects colchicine retina cream revolve //srqypg.com/product/aldara/#aldara-on-line aldara canadian pharmacy //ivapelocal.com/cipro/#cipro cipro for uti //chesscoachcentral.com/product/co ... e-en-ligne buying colchicine online //americanartgalleryandgifts.com/retin-a/#retin-a retin-a nanogram chorioretinopathy, despite tuberculoma.Statistics: Posted by Guest - Sun Jan 19, 2020 7:11 ...
Retrospective study of pediatric patients with SCD followed in the medical retina unit of Jules-Gonin Eye Hospital .The study group was compared to a control group matched for age, sex and ethnicity. Retinal thinning, macular splaying (foveal diameter), foveal depth and subfoveal choroidal thickness were measured using OCT (Heidelberg Engineering, Germany ...
FUNKCE TUKOVÉ TKÁNĚ  tepelně izolační  mechanická ochrana  energetická rezerva  endokrinní orgán  pro- a antiinflamační funkce
Nefrotický syndrom I - obecná část 1) definice nefrotického syndromu 2) underfilling teorie vzniku otoků u nefrotického syndromu 3) overflow teorie vzniku otoků u nefrotického syndromu 4) terapie otoků u nefrotického syndromu, diuretika 5) terapie hyperlipidémie, prevence tromboz
Learn About Retinal Artery Occlusions, Retinal Vein Occlusions, Central Serous Retinopathy, Epiretinal Membrane, Retinal Tear/Detachment, Myopic Degeneration, Retinitis Pigmentosa, Uveltis, Retinopathy of Prematurity, Macular Hole, and Anti-VEGF For Other Retinal Diseases.
Following are symptoms for blurred vision : accommodative disorder, albinism, amblyopia, aniridia, asteroid hyalosis, astigmatism, cataract, central serous retinopathy, computer vision syndrome, contact lens problem, corneal abrasion, corneal dystrophy, corneal erosion, cranial nerve palsy, drugs, epiretinal membrane, eye tumor, foreign body, fungal keratitis eye infection, glaucoma, hypotony, keratoconus, lens dislocation, macular degeneration, meibomianitis, migraine, neuroretinitis,…
Twenty-two tumours from 19 eyes of 17 patients were included in the study. Mean age at presentation was 43.5 years (range-15-68 years). Mean presenting BCVA was +1.10 Log MAR. Secondary tumours were found in 68% eyes. At presentation, mean basal tumour dimension of primary tumours was 7.17 mm and secondary tumours was 9.92 mm. Most common association of secondary VPT was Coats disease (n=5) followed by retinal vasculitis (n=2), Polypoidal choroidal vasculopathy (n=2), Familial exudative vitreorretinopathy (n=2) and traumatic chorioretinopathy (n=2). Ten tumours (45%) involved the inferior quadrant. tumour associated features were intra/sub-retinal exudates (n=14), vitritis (n=7), sub-retinal fluid (n=5), vitreous haemorrhage (n=3), pre-retinal fibrosis (n=3), epiretinal membrane (n=3) and sub-retinal blood (n=2). Treatment included transconjunctival cryotherapy (n=9), intravitreal or oral steroids (n=4), laser (n=3), transconjunctival cryotherapy with encirclage (n=1), transconjunctival ...
The impact of pregnancy on the choroid is still under investigation. The aim of this study is to compare choroidal thickness measurements of healthy pregnant women in the third trimester and healthy non-pregnant women using spectral-domain optical coherence tomography (OCT). This cross-sectional study included 122 eyes of 61 women, divided into two groups: 27 healthy pregnant women in the third trimester and 34 age-matched healthy non-pregnant women. Choroidal thickness was measured using Enhanced Depth Imaging OCT at ten different locations: at the fovea and every 500 µm from the fovea up to 2500 µm temporally and up to 2000 µm nasally. There were no significant differences in the ten measurements of choroidal thickness comparing both groups. Mean subfoveal choroidal thickness was 304.1 + 9.6 µm in the control group and 318.1 + 15.6 µm in the pregnant women group (p = 0.446). There was also no statistically significant association between gestational age and choroidal thickness measurements in the
The white dot syndromes are a group of inflammatory chorioretinopathies of unknown etiology which have in common a unique and characteristic appearance of multiple yellow-white lesions affecting multiple layers of the retina, retinal pigment epithelium (RPE), choriocapillaris, and the choroid. They also have overlapping clinical features. We discuss acute retinal pigment epitheliopathy, multiple evanescent white dot syndrome, acute posterior multifocal placoid pigment epitheliopathy, multifocal choroiditis and panuveitis, acute zonal occult outer retinopathy, birdshot chorioretinopathy, and serpiginous choroidopathy. Some of these diseases are associated with a viral prodrome suggesting a possible viral/infectious etiology, while others are associated with a number of systemic processes suggesting an autoimmune etiology. We also review the presentation, evaluation/diagnosis, and treatment of these entities as well as the prognosis. Where applicable we discuss recent advancements in diagnosing and
The clinical translational unit run at the Christian Medical College (CMC) led by Alok Srivastava, the Centre for Stem Cell Research (CSCR) is another endeavour where clinical translation is being honed into three main areas of focus. Two are founded on core interests in gene therapy for hemophilia (based on the recognition of underutilized AAV vectors in collaboration with Amit Nathwani at UCL, London, UK and Arun Srivastava at UFL, Gainesville, USA) and thalassemia (based on lenti viral vectors in collaboration with Trent Spencer at Emory University, USA).The third is on a musculoskeletal regeneration programme led by Vrisha Madhuri. The outcome of this latter focus is currently undergoing clinical trials in articular and physeal cartilage replacement, along with bone and muscle regeneration. The major challenge at CSCR for its programmes is to ensure clear translational goals for each activity and team. The procedures that will help achieve this are in the process of being developed with a ...
CSC Scientific Company provides equipment solutions for Moisture, Liquid Properties (surface tension-viscosity-density) and Particle Size Analysis problems.
Abouammoh, Marwan A. (2015). "Advances in the treatment of central serous chorioretinopathy". Saudi Journal of Ophthalmology. ... also known as central serous chorioretinopathy, CSC). A variety of steroid medications, from anti-allergy nasal sprays (Nasonex ... "Corticosteroids and central serous chorioretinopathy". Ophthalmology. 109 (10): 1834-7. doi:10.1016/S0161-6420(02)01117-X. PMID ... Clinical and experimental evidence indicates that corticosteroids can cause permanent eye damage by inducing central serous ...
Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P (2015). "Interventions for central serous chorioretinopathy: a network meta- ... Eplerenone is being explored as a treatment for central serous retinopathy. It is expected that as an antimineralocorticoid, ...
Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D (October 1997). "Central serous chorioretinopathy associated with ... Nasal corticosteroids may be associated with central serous retinopathy. Beclometasone dipropionate is the INN modified and ...
"Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy". Clinical Ophthalmology. 7: ... Verteporfin is also used off-label for the treatment of central serous retinopathy. Verteporfin is given intravenously, 15 ...
"Verteporfin (Visudyne®) photo-dynamic therapy in the management of chronic central serous chorioretinopathy" (PDF). Northern ...
Central Serous Chorioretinopathy (CSCR) which can produce micropsia predominantly affects persons between the ages of 20 and 50 ... or central serous retinopathy), by changes in the brain (such as from traumatic brain injury, epilepsy, migraines, prescription ... For this test, patients are asked to look at a grid, and distortions or blank spots in the patient's central field of vision ... CSCR is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the ...
Other retinal problems can lead to a temporary disturbance of colour vision, such as Central serous chorioretinopathy, Macular ... such as macular edema and central serous chorioretinopathy. An Amsler grid can be supplied by an ophthalmologist so that the ... The central vision can be affected eventually as well. People with this problem may have trouble getting around in the dark. ... Small, rapid pin-point sparks of light can be seen darting about in the central vision. Some people may think that these sparks ...
Central core disease Central diabetes insipidus Central nervous system protozoal infections Central serous chorioretinopathy ... Central type neurofibromatosis Centromeric instability immunodeficiency syndrome Centronuclear myopathy Centrotemporal epilepsy ... g Congenital cardiovascular disorder Congenital cardiovascular malformations Congenital cardiovascular shunt Congenital central ... Chorea Choreoacanthocytosis amyotrophic Choreoathetosis familial paroxysmal Choriocarcinoma Chorioretinitis Chorioretinopathy ...
Separation of retinal layers Central serous chorioretinopathy (H35.8) Other specified retinal disorders (H36) Retinal disorders ... Central retinal artery occlusion (H34.2) Other retinal artery occlusions Hollenhorst's plaque (H34.8) Other retinal vascular ... occlusions Central retinal vein occlusion (H34.9) Retinal vascular occlusion, unspecified (H35) Other retinal disorders (H35.0 ...
... a printed security code on payment cards such as credits and debit cards Central serous chorioretinopathy, an eye disease ...
... (CSR), also known as central serous chorioretinopathy (CSC or CSCR), is an eye disease which causes ... Central Serous Chorioretinopathy and Topical NSAIDs". Retinal Physician. Retrieved 15 October 2017. "Central Serous ... Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P (2015). "Interventions for central serous chorioretinopathy: a network meta- ... Kanyange, ML; De Laey, JJ (2002). "Long-term follow-up of central serous chorioretinopathy (CSCR)". Bulletin de la Societe ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Symmetrical reticular opacities form in the superficial central cornea of both eyes at about 4-5 years of age in Reis-Bücklers ... Lattice dystrophy starts as fine branching linear opacities in Bowman's layer in the central area and spreads to the preiphery ... Historically, an accumulation of small gray variable shaped punctate opacities of variable shape in the central deep corneal ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Nuclear sclerosis is the most common type of cataract, and involves the central or 'nuclear' part of the lens. This eventually ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... and the meninges of the central nervous system.[2][3][4][5][6] ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular ... and multiple exudative bullous serous retinal detachments.[2][5][6] ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... and sight in the central visual field.[4] The progression of disease symptoms occurs in a symmetrical manner, with both the ... eventually extending into the central visual field as tunnel vision increases. Visual acuity and color vision can become ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... The central image represents forward gaze, and each image around it represents gaze in that direction (for example, in the ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... The head may be tilted in such a way that one of the floaters drifts towards the central axis of the eye. In the sharpened ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... The central retinal vein is the venous equivalent of the central retinal artery and, like that blood vessel, it can suffer from ... Central Retinal Vein Occlusion at eMedicine *^ a b Braithwaite T, Nanji AA, Lindsley K, Greenberg PB (2014). "Anti-vascular ... Since the central retinal artery and vein are the sole source of blood supply and drainage for the retina, such occlusion can ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... "Central nervous system tuberculosis". African Health Sciences. 11 (1): 116-27. PMC 3092316. PMID 21572867 ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... PMD lacks apical corneal scarring, Rizutti's phenomenon, Munson's sign, and the central corneal thickness is usually normal.[2] ... The center of the cornea shows normal thickness, with an intact central epithelium, but the inferior cornea exhibits a ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
... also known as central serous chorioretinopathy, CSC).[6] A variety of steroid medications, from anti-allergy nasal sprays ( ... "Advances in the treatment of central serous chorioretinopathy". Saudi Journal of Ophthalmology. 29 (4): 278-286. doi:10.1016/j. ... "Corticosteroids and central serous chorioretinopathy". Ophthalmology. 109 (10): 1834-7. doi:10.1016/S0161-6420(02)01117-X. PMID ... Clinical and experimental evidence indicates that corticosteroids can cause permanent eye damage by inducing central serous ...
Objective: Central serous chorioretinopathy (CSC) is a retinal disorder characterized by an accumulation of serous fluid under ... Topical Interferon Gamma-1b for Central Serous Chorioretinopathy. The safety and scientific validity of this study is the ... Central Serous Chorioretinopathy. Interferon-Gamma (IFN-Gamma). Jakstat. Retinal Eye Disease. Macular Eye Disease. CSC. ... Central Serous Chorioretinopathy. Eye Diseases. Interferons. Interferon-gamma. Antineoplastic Agents. Antiviral Agents. Anti- ...
Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy. The safety and scientific validity of this study is ... Central Serous Chorioretinopathy Drug: Verteporfin PDT, half-dose Drug: verteporfin PDT, half-fluence ... Central Serous Chorioretinopathy. Retinal Diseases. Eye Diseases. Verteporfin. Photosensitizing Agents. Dermatologic Agents. ... use different modification of verteporfin PDT to treat prolonged unresolved central serous chorioretinopathy ...
To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy ( ... Central serous chorioretinopathy (CSC) is a well-characterized self-limiting disorder leading to serous neurosensory elevation ... Spide RF,Campeas L,Haas A,Yannuzzi LA,Fisher YL,Guyer DR,Slakter JS,Sorenson JA,Orlock DA,Central serous chorioretinopathy in ... Central Serous Chorioretinopathy / drug therapy*, pathology. Ethamsylate / administration & dosage. Fluorescein Angiography. ...
Other common complaints include micropsia, metamorphopsia, hyperopic (most common) or myopic shift, central scotoma, and ... cause a serous detachment of the neurosensory retina. Recurrence occurs in about 31% patients with CSCR,[3] though the ... CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. ... Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic ...
A retrospective chart review of newly diagnosed cases of central serous chorioretinopathy revealed 11 patients, seven men and ... After resolution of the central serous chorioretinopathy, patients were left with subtle alterations in the retinal pigment ... Firstly, the presence of subretinal exudation does not necessarily rule out the diagnosis of central serous chorioretinopathy. ... Secondly, pathophysiological theories of central serous chorioretinopathy must explain how the plaques are deposited behind the ...
Endocrine And Metabolic Abnormalities In Central Serous Chorioretinopathy You will receive an email whenever this article is ... R Haimovici, S Rumelt, J Melby; Endocrine And Metabolic Abnormalities In Central Serous Chorioretinopathy . Invest. Ophthalmol ... To investigate and identify endocrine and metabolic abnormalities in patients with central serous chorioretinopathy (CSCR). ...
Changes in axial length and subfoveal choroidal thickness after photodynamic therapy for central serous chorioretinopathy ... Changes in axial length and subfoveal choroidal thickness after photodynamic therapy for central serous chorioretinopathy ... for central serous chorioretinopathy (CSC). Methods : This retrospective, observational case series involved 48 eyes (24 CSC ... Changes in axial length and subfoveal choroidal thickness after photodynamic therapy for central serous chorioretinopathy. ...
Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months. ... Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months. ... The health of the RPE in central serous chorioretinopathy (CSC) is often assessed by SW-AF. However, changes of SW-AF over time ... Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months.. Invest. Ophthalmol ...
A patient with central serous chorioretinopathy with a detachment of the macula beneath the fovea with fibrin in that space. ... A major interest in a well-known and not uncommon disorder of the macula is central serous chorioretinopathy. This is a ...
Figure 1 Central serous chorioretinopathy: a pathogenetic model. Abbreviations: CSCR, central serous chorioretinopathy; PAI-1, ... angiography of central serous chorioretinopathy. Int Ophthalmol. 1986;9: 37-41. 10. Piccolino FC, Borgia L. Central serous ... Central serous chorioretinopathy in endogenous chorioretinopathy. Arch Ophthalmol. 1993;111:1229-1233. 16. Haimovici R, Rumelt ... Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431-448. 20. Haimovici R, Koh S, Gagnon DR, ...
Characterization of Central Serous Chorioretinopathy by Optical Coherence Tomography Sub-Analysis D. Yu; S. Sadda; P.G. Updike ... Characterization of Central Serous Chorioretinopathy by Optical Coherence Tomography Sub-Analysis You will receive an email ... D. Yu, S. Sadda, P.G. Updike, A. Walsh; Characterization of Central Serous Chorioretinopathy by Optical Coherence Tomography ... provides superb morphologic information about the state of the retina in diseases such as central serous chorioretinopathy ( ...
Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. Jeffrey J. Mattingly, Alec Lee Amram, ... Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. / Mattingly, Jeffrey J.; Amram, Alec Lee ... Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. In: Canadian Journal of Ophthalmology. ... Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. Canadian Journal of Ophthalmology. 2018 ...
Longitudinal Imaging of Cone Inner and Outer Segment Mosaics in Central Serous Chorioretinopathy. ... Longitudinal Imaging of Cone Inner and Outer Segment Mosaics in Central Serous Chorioretinopathy ... from central serous chorioretinopathy (CSCR). Methods : Retinal areas overlying and adjacent to SRF were imaged in 15 subjects ... Longitudinal Imaging of Cone Inner and Outer Segment Mosaics in Central Serous Chorioretinopathy. . Invest. Ophthalmol. Vis. ...
Purpose: : Central serous chorioretinopathy (CSC) is a retinal disorder characterized by pigment epithelial decompensation ... Kristen A. Burwick, Michael B. Wells; Presence of Pigment Epithelial Detachment in Central Serous Chorioretinopathy using High ... Presence of Pigment Epithelial Detachment in Central Serous Chorioretinopathy using High Definition Optical Coherence ... Presence of Pigment Epithelial Detachment in Central Serous Chorioretinopathy using High Definition Optical Coherence ...
... is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the choriocapillaris ... encoded search term (Central Serous Chorioretinopathy) and Central Serous Chorioretinopathy What to Read Next on Medscape. ... Central serous chorioretinopathy (CSCR) is a disease in which a serous detachment of the neurosensory retina occurs over an ... Central Serous Chorioretinopathy. Updated: Jun 18, 2019 * Author: Kean Theng Oh, MD; Chief Editor: Andrew A Dahl, MD, FACS more ...
... Eliana Costanzo,1,2 Salomon Yves Cohen,1 ... To analyze optical coherence tomography angiography (OCTA) findings in eyes with central serous chorioretinopathy (CSC) and to ... which were frequently associated with serous retinal detachment, presence of dark spots (7/33 eyes) which were frequently ...
Background To evaluate the retinal and choroidal alterations in steroid-associated central serous chorioretinopathy (CSC) in ... Central serous chorioretinopathy (CSC) is a common chorioretinal disorder, characterized by serous retinal detachment in the ... Central serous chorioretinopathy: A seasonal variation? Br J Ophthalmol. 1984;68(10):724-6.CrossRefPubMedPubMedCentralGoogle ... Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68(11):815-20.CrossRefPubMedPubMedCentralGoogle ...
All patients had central serous cho... Arm/Group Description All patients had central serous chorioretinopathy and were treated ... Eplerenone for Central Serous Chorioretinopathy. The safety and scientific validity of this study is the responsibility of the ... Patients with central serous chorioretinopathy were recruited in the ophthalmology clinic at Tufts Medical Center in Boston, MA ... Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010 Dec;24(12):1743-56. doi: 10.1038/ ...
... natural history and pathophysiology of central serous chorioretinopathy (CSCR). The ... including idiopathic central serous choroidopathy, central serous retinopathy and diffuse retinal pigment epitheliopathy. ... natural history and pathophysiology of central serous chorioretinopathy (CSCR).. The authors conducted a literature search for ... Clinically, CSCR can present acutely as serous neurosensory detachment that often resolves spontaneously within six months, as ...
Eplerenone for Central Serous Chorioretinopathy. The safety and scientific validity of this study is the responsibility of the ... Central Serous Chorioretinopathy. Eplerenone. Optical Coherence Tomography. Enhanced Depth Imaging. Subretinal Fluid. ... Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010 Dec;24(12):1743-56. doi: 10.1038/ ... Finasteride for chronic central serous chorioretinopathy. Retina. 2011 Apr;31(4):766-71. doi: 10.1097/IAE.0b013e3181f04a35. ...
Most cases of central serous retinopathy clear up in one or two months without any treatment. During this time, your ...
... Cheng Li,1 Xiaoxiao Feng,1 Xin ... To evaluate the retinal vessel oxygen saturation in central serous chorioretinopathy (CSC) cases among the Chinese. Methods. ...
Central serous chorioretinopathy (CSC) is a relatively frequent eye disease in younger patients. It is characterized by serous ... Treatment Trial for Acute Central Serous Chorioretinopathy. The safety and scientific validity of this study is the ... The purpose of this study is to evaluate the effect of micropulse laser (MPL) on acute central serous chorioretinopathy ... Trial to Evaluate the Effects of 577nm Micropulse Laser vs Traditional Laser Therapy on Acute Central Serous Chorioretinopathy ...
... with central serous chorioretinopathy who had symptoms for more than three months, a history of recurrent untreated central ... Anti-VEGF injection may help resolve central serous chorioretinopathy particularly in cases that do not resolve spontaneously, ... for the treatment of central serous chorioretinopathy. The results suggest a possible role of vascular endothelial growth ... factor in the pathogenesis of central serous chorioretinopathy.. The authors retrospectively reviewed the charts of six ...
... population-based study found that patients with central serous chorioretinopathy (CSCR) had a significantly higher coronary ... This retrospective, population-based study found that patients with central serous chorioretinopathy (CSCR) had a significantly ...
  • The purpose of this study is to evaluate the effectiveness as well as the detrimental influence of half-dose and half-fluence modification of verteporfin photodynamic therapy (PDT) for the treatment of prolonged unresolved central serous chorioretinopathy (CSCR). (clinicaltrials.gov)
  • Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy and branch retinal vein occlusion. (aao.org)
  • CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. (aao.org)
  • No underlying pathophysiologic mechanisms have been proven, but CSCR is thought to occur due to hyper-permeable choroidal capillaries, which, in association with retinal pigment dysfunction, cause a serous detachment of the neurosensory retina. (aao.org)
  • The disease was first recognized by Albrecht von Graefe in 1866 and was named central recurrent retinitis. (aao.org)
more